{"id":12003,"date":"2021-05-25T16:08:10","date_gmt":"2021-05-25T20:08:10","guid":{"rendered":"https:\/\/www.bu.edu\/ctsi\/?p=12003"},"modified":"2021-05-25T16:08:10","modified_gmt":"2021-05-25T20:08:10","slug":"ctsa-ansible-may-2021","status":"publish","type":"post","link":"https:\/\/www.bu.edu\/ctsi\/2021\/05\/25\/ctsa-ansible-may-2021\/","title":{"rendered":"CTSA Ansible – May 2021"},"content":{"rendered":"\n\n\n
\"CTSA<\/a><\/td>\n\"CLIC<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

<\/p>\n

THE SPOTLIGHT<\/a>\u00a0<\/span>|<\/span>\u00a0<\/span>WHAT’S NEW<\/a>\u00a0<\/span>|<\/span>\u00a0<\/span>GET INVOLVED<\/a>\u00a0<\/span>|<\/span>\u00a0<\/span>CONSORTIUM CORNER<\/a><\/p>\n

Mike’s Blog May 2021<\/strong><\/p>\n

A Note from Joni<\/h4>\n

Guest Blog by Dr. Joni L. Rutter, NCATS Acting Director<\/em><\/p>\n

Greetings!<\/p>\n

It is my pleasure to be a guest on Mike\u2019s Blog this month. While I have not yet met some of you, I hope this can serve as an introduction in my new capacity as Acting Director of the National Center for Advancing Translational Sciences.<\/p>\n

It has just been a few weeks since Dr. Austin\u2019s departure, and you may be wondering how this leadership change could affect you. I can assure you that the CTSA Program will not skip a beat. I have been and remain a committed super fan of the CTSA Program! In fact, I could not be more excited about the CTSA program\u2019s future. I have been deeply involved in the N3C and look forward to translating that exceptional \u201ccan-do-ness\u201d energy to other areas of the CTSA Program as we continue to approach many critical clinical research and translational science endeavors. To Access Full Blog –\u00a0<\/span>Click Here<\/a>.<\/p>\n\n\n\n
\n

THE SPOTLIGHT<\/span><\/h2>\n
\n

CTSA Program Hubs Will Help Implement the ACTIV-6 Clinical Trial<\/span><\/h3>\n

<\/span><\/p>\n

\n
\n
\n

The National Institutes of Health will fund a large, randomized, placebo controlled Phase 3 clinical trial to test several existing prescription and over-the-counter medications for people to self-administer to treat symptoms of COVID-19. The trial is part of the\u00a0Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV)<\/u><\/a>\u00a0partnership and overseen by NCATS.
\n<\/span>The Duke Clinical Research Institute, Durham, North Carolina, an NCATS-funded\u00a0Clinical and Translational Science Awards (CTSA) Program<\/u><\/strong><\/a>\u00a0hub, will serve as the clinical coordinating center, and the Vanderbilt Institute for Clinical and Translational Research CTSA Program hub will serve as the trial\u2019s data coordinating center. Enrollment will focus on communities that are significantly affected by COVID-19 but lack access to major academic medical centers, where large clinical trials usually take place.<\/span><\/p>\n<\/div>\n

For More Information ><\/a><\/span><\/div>\n<\/div>\n<\/div>\n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n\n\n\n
\n

WHAT’S NEW<\/h4>\n
\n
\n

– UPCOMING EVENTS –<\/h3>\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
<\/div>\n<\/div>\n
\n

NEW: NCATS Advisory Council (June 10-11, 2021)<\/h3>\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
\n

Several CTSA concepts will be presented:\u00a0<\/span>https:\/\/ncats.nih.gov\/advisory\/council<\/a>.<\/p>\n<\/div>\n<\/div>\n

\n

Un-Meeting: Exploring the Inclusion of Community Hospitals in Clinical Research<\/h4>\n<\/div>\n
\n

<\/p>\n

\n

Save the date! This NCATS Un-Meeting will focus on the successful outreach and recruitment of community hospital participants into clinical trials prior to and during the COVID-19 pandemic. What lessons were learned and how can these strategies be implemented for future clinical trials?<\/p>\n

Registration and details coming soon.<\/p>\n<\/div>\n

Announcement page ><\/a><\/div>\n<\/div>\n
\n
\n<\/div>\n

NEW: Virtual Workshop: Enhancing the Participation of Research Investigators in the Biomedical Workforce, May 18-20, 2021<\/h4>\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
\n

In partnership with the UCLA Clinical and Translational Science Institute (CTSI) and Charles R. Dew University of Medicine and Science (CDU) Urban Health Institute, the National Institute of Allergy and Infectious Diseases (NIAID) is hosting their regional research funding workshop with Charles R. Drew University of Medicine and Science (CDU) and UCLA titled \u201cEnhancing the Participation of Research Investigators in the Biomedical Workforce.\u201d This three-day workshop May 18-20, 2021 is free and open to pre and post-doctoral fellows, clinician-scientists, as well as early-stage and mid-career research investigators at any institution.<\/p>\n<\/div>\n

More information and register here ><\/a><\/div>\n
\n
\n
\n

– UPDATES AND REMINDERS FROM NIH –<\/h3>\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
NEW: Funding Opportunity Announcement (FOA) and Accompanying Notice of Special Interest (NOSI): Clinical and Translational Science Award (CTSA) Consortium-Wide Centers: Resources for Rapid Demonstration and Dissemination (C3-R2D2) \u2013 Health Informatics<\/span><\/div>\n<\/div>\n
\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
\n

NCATS will support applications for Clinical and Translational Science Award (CTSA) Program consortium-wide resource centers that will rapidly demonstrate and disseminate innovative resources (to include capabilities) that have demonstrated impact at a local or national level to the wider consortium. Only applications responding to a NOSI will be allowed to apply to this FOA.Due date for NOT-TR-21-025: June 21, 2021<\/strong>. More information onPAR-21-203<\/a>andNOT-TR-21-025<\/a>.<\/p>\n<\/div>\n<\/div>\n

NEW: Notice of Intent to Publish Research Opportunity Announcements for the NIH Post-Acute Sequelae of SARS-CoV-2 Infection Initiative: PASC Data Repositories and Mobile Health Platform<\/p>\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
\n

NIH plans to publish two additional ROAs in support of the PASC Initiative, one on PASC Data Repositories and one on a Mobile Health Platform. The solicited research will improve understanding of and develop strategies to prevent and treat post-acute manifestations of SARS-CoV-2 infection across the lifespan. Publication of the ROAs is expected in May 2021. Projects will be funded utilizing NIH\u2019s Other Transaction Authority (OTA), which offers flexibility and the ability to engage partners in collaborative innovation and problem solving. Initial awards are anticipated to be made in June 2021. We will issue broad notification to the community when the ROAs are published. Please direct all inquiries to:\u00a0<\/span>NHLBI_OTA@mail.nih.gov<\/a>.<\/p>\n<\/div>\n

More information ><\/a><\/div>\n<\/div>\n
\n
\n

NEW: Funding Opportunity Announcements for RADx-UP Phase II<\/p>\n\n\n\n
\"\"<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n
\n